Evidence map›Paper›PMID 34120635›Full record

ReviewBMC sports science, medicine & rehabilitation2021

Peak week recommendations for bodybuilders: an evidence based approach.

Guillermo Escalante, Scott W Stevenson, Christopher Barakat, Alan A Aragon, Brad J Schoenfeld

Abstract readReview
In one paragraph

Review in BMC sports science, medicine & rehabilitation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Premature Death in Bodybuilders: What Do We Know?Sports medicine (Auckland, N.Z.) · 2023
    Article
  18. Article
  19. Nutritional and Non-Nutritional Strategies in Bodybuilding: Impact on Kidney Function.International journal of environmental research and public health · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guillermo EscalanteDepartment of Kinesiology, California State University- San Bernardino, CA, San Bernardino, USA.
Scott W StevensonIntegrative Bodybuilding LLC, FL, Tampa, USA.
Christopher BarakatCompetitive Breed LLC, FL, Tampa, USA.
Alan A AragonDepartment of Family and Consumer Sciences, California State University- Northridge, Los Angeles, CA, USA.
Brad J SchoenfeldHealth Sciences Department, Lehman College, NY, Bronx, USA. brad@workout911.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bodybuilding is a competitive endeavor where a combination of muscle size, symmetry, "conditioning" (low body fat levels), and stage presentation are judged. Success in bodybuilding requires that competitors achieve their peak physique during the day of competition. To this end, competitors have been reported to employ various peaking interventions during the final days leading to competition. Commonly reported peaking strategies include altering exercise and nutritional regimens, including manipulation of macronutrient, water, and electrolyte intake, as well as consumption of various dietary supplements. The primary goals for these interventions are to maximize muscle glycogen content, minimize subcutaneous water, and reduce the risk abdominal bloating to bring about a more aesthetically pleasing physique. Unfortunately, there is a dearth of evidence to support the commonly reported practices employed by bodybuilders during peak week. Hence, the purpose of this article is to critically review the current literature as to the scientific support for pre-contest peaking protocols most commonly employed by bodybuilders and provide evidence-based recommendations as safe and effective strategies on the topic.

Indexed as

BodybuildingCompetitionContestPeaking

Identifiers

PMID34120635
PMCPMC8201693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.